Phenotypical variability and atypical presentations in a French cohort of Andersen-Tawil syndrome.
KCNJ2
Andersen-Tawil syndrome
channelopathy
long-exercise ENMG test
periodic paralysis
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
31
03
2022
received:
27
01
2022
accepted:
18
04
2022
pubmed:
24
4
2022
medline:
19
7
2022
entrez:
23
4
2022
Statut:
ppublish
Résumé
Andersen-Tawil syndrome (ATS) is a skeletal muscle channelopathy caused by KCNJ2 mutations, characterized by a clinical triad of periodic paralysis, cardiac arrhythmias and dysmorphism. The muscle phenotype, particularly the atypical forms with prominent permanent weakness or predominantly painful symptoms, remains incompletely characterized. A retrospective clinical, histological, electroneuromyography (ENMG) and genetic analysis of molecularly confirmed ATS patients, diagnosed and followed up at neuromuscular reference centers in France, was conducted. Thirty-five patients from 27 unrelated families carrying 17 different missense KCNJ2 mutations (four novel mutations) and a heterozygous KCNJ2 duplication are reported. The typical triad was observed in 42.9% of patients. Cardiac abnormalities were observed in 65.7%: 56.5% asymptomatic and 39.1% requiring antiarrhythmic drugs. 71.4% of patients exhibited dysmorphic features. Muscle symptoms were reported in 85.7%, amongst whom 13.3% had no cardiopathy and 33.3% no dysmorphic features. Periodic paralysis was present in 80% and was significantly more frequent in men. Common triggers were exercise, immobility and carbohydrate-rich diet. Ictal serum potassium concentrations were low in 53.6%. Of the 35 patients, 45.7% had permanent weakness affecting proximal muscles, which was mild and stable or slowly progressive over several decades. Four patients presented with exercise-induced pain and myalgia attacks. Diagnostic delay was 14.4 ± 9.5 years. ENMG long-exercise test performed in 25 patients (71.4%) showed in all a decremental response up to 40%. Muscle biopsy performed in 12 patients revealed tubular aggregates in six patients (associated in two of them with vacuolar lesions), dystrophic features in one patient and non-specific myopathic features in one patient; it was normal in four patients. Recognition of atypical features (exercise-induced pain or myalgia and permanent weakness) along with any of the elements of the triad should arouse suspicion. The ENMG long-exercise test has a high diagnostic yield and should be performed. Early diagnosis is of utmost importance to improve disease prognosis.
Sections du résumé
BACKGROUND AND PURPOSE
Andersen-Tawil syndrome (ATS) is a skeletal muscle channelopathy caused by KCNJ2 mutations, characterized by a clinical triad of periodic paralysis, cardiac arrhythmias and dysmorphism. The muscle phenotype, particularly the atypical forms with prominent permanent weakness or predominantly painful symptoms, remains incompletely characterized.
METHODS
A retrospective clinical, histological, electroneuromyography (ENMG) and genetic analysis of molecularly confirmed ATS patients, diagnosed and followed up at neuromuscular reference centers in France, was conducted.
RESULTS
Thirty-five patients from 27 unrelated families carrying 17 different missense KCNJ2 mutations (four novel mutations) and a heterozygous KCNJ2 duplication are reported. The typical triad was observed in 42.9% of patients. Cardiac abnormalities were observed in 65.7%: 56.5% asymptomatic and 39.1% requiring antiarrhythmic drugs. 71.4% of patients exhibited dysmorphic features. Muscle symptoms were reported in 85.7%, amongst whom 13.3% had no cardiopathy and 33.3% no dysmorphic features. Periodic paralysis was present in 80% and was significantly more frequent in men. Common triggers were exercise, immobility and carbohydrate-rich diet. Ictal serum potassium concentrations were low in 53.6%. Of the 35 patients, 45.7% had permanent weakness affecting proximal muscles, which was mild and stable or slowly progressive over several decades. Four patients presented with exercise-induced pain and myalgia attacks. Diagnostic delay was 14.4 ± 9.5 years. ENMG long-exercise test performed in 25 patients (71.4%) showed in all a decremental response up to 40%. Muscle biopsy performed in 12 patients revealed tubular aggregates in six patients (associated in two of them with vacuolar lesions), dystrophic features in one patient and non-specific myopathic features in one patient; it was normal in four patients.
DISCUSSION
Recognition of atypical features (exercise-induced pain or myalgia and permanent weakness) along with any of the elements of the triad should arouse suspicion. The ENMG long-exercise test has a high diagnostic yield and should be performed. Early diagnosis is of utmost importance to improve disease prognosis.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2398-2411Informations de copyright
© 2022 European Academy of Neurology.
Références
Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell. 2001;105(4):511-519. doi:10.1016/S0092-8674(01)00342-7
Horga A, Rayan DLR, Matthews E, et al. Prevalence study of genetically defined skeletal muscle channelopathies in England. Neurology. 2013;80(16):1472-1475. doi:10.1212/WNL.0b013e31828cf8d0
Stunnenberg BC, Raaphorst J, Deenen JCW, et al. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. Neuromuscul Disord. 2018;28(5):402-407. doi:10.1016/J.NMD.2018.03.006
Andersen ED, Krasilnikoff PA, Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies: a new syndrome? Acta Paediatrica. 1971;60(5):559-564. doi:10.1111/j.1651-2227.1971.tb06990.x
Tawil R, Ptacek LJ, Pavlakis SG, et al. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol. 1994;35(3):326-330. doi:10.1002/ana.410350313
Fialho D, Griggs RC, Matthews E. Periodic paralysis. Handb Clin Neurol. 2018;148:505-520. doi:10.1016/B978-0-444-64076-5.00032-6
Arzel-Hézode M, McGoey S, Sternberg D, Vicart S, Eymard B, Fontaine B. Glucocorticoids may trigger attacks in several types of periodic paralysis. Neuromuscul Disord. 2009;19(3):217-219. doi:10.1016/J.NMD.2008.12.008
Donaldson MR, Yoon G, Fu YH, Ptacek LJ. Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity. Ann Med. 2004;36:92-97. doi:10.1080/17431380410032490
Davies NP, Imbrici P, Fialho D, et al. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology. 2005;65(7):1083-1089. doi:10.1212/01.wnl.0000178888.03767.74
Pérez-Riera AR, Barbosa-Barros R, Samesina N, et al. Andersen-Tawil syndrome: a comprehensive review. Cardiol Rev. 2021;29(4):165-177. doi:10.1097/CRD.0000000000000326
Nguyen HL, Pieper GH, Wilders R. Andersen-Tawil syndrome: clinical and molecular aspects. Int J Cardiol. 2013;170(1):1-16. doi:10.1016/j.ijcard.2013.10.010
Dolci C, Sansone VA, Gibelli D, Cappella A, Sforza C. Distinctive facial features in Andersen-Tawil syndrome: a three-dimensional stereophotogrammetric analysis. Am J Med Genet Part A. 2021;185(3):781-789. doi:10.1002/ajmg.a.62040
Yoon G, Quitania L, Kramer JH, Fu YH, Miller BL, Ptáček LJ. Andersen-Tawil syndrome: definition of a neurocognitive phenotype. Neurology. 2006;66(11):1703-1710. doi:10.1212/01.wnl.0000218214.64942.64
Fournier E, Arzel M, Sternberg D, et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol. 2004;56(5):650-661. doi:10.1002/ana.20241
Fournier E, Tabti N. Clinical electrophysiology of muscle diseases and episodic muscle disorders. Handb Clin Neurol. 2019;161:269-280. doi:10.1016/B978-0-444-64142-7.00053-9
Bendahhou S, Fournier E, Sternberg D, et al. In vivo and in vitro functional characterization of Andersen's syndrome mutations. J Physiol. 2005;565(3):731-741. doi:10.1113/jphysiol.2004.081620
Kimura H, Zhou J, Kawamura M, et al. Phenotype variability in patients carrying KCNJ2 mutations. Circ Cardiovasc Genet. 2012;5(3):344-353. doi:10.1161/CIRCGENETICS.111.962316
Kokubun N, Aoki R, Nagashima T, et al. Clinical and neurophysiological variability in Andersen-Tawil syndrome. Muscle Nerve. 2019;60(6):752-757. doi:10.1002/mus.26705
Mazzanti A, Guz D, Trancuccio A, et al. Natural history and risk stratification in Andersen-Tawil syndrome type 1. J Am Coll Cardiol. 2020;75(15):1772-1784. doi:10.1016/j.jacc.2020.02.033
Delannoy E, Sacher F, Maury P, et al. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation. Europace. 2013;15(12):1805-1811. doi:10.1093/europace/eut160
Miller TM, Dias Da Silva MR, Miller HA, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004;63(9):1647-1655. doi:10.1212/01.WNL.0000143383.91137.00
Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet. 1995;56(2):374-380.
Renner DR, Ptácek LJ. Periodic paralyses and nondystrophic myotonias. Adv Neurol. 2002;88:235-252.
Murphy LB, Schreiber-Katz O, Rafferty K, et al. Global FKRP registry: observations in more than 300 patients with limb girdle muscular dystrophy R9. Ann Clin Transl Neurol. 2020;7(5):757-766. doi:10.1002/acn3.51042
Libell EM, Richardson JA, Lutz KL, et al. Cardiomyopathy in limb girdle muscular dystrophy R9, FKRP related. Muscle Nerve. 2020;62(5):626-632. doi:10.1002/mus.27052
Song J, Luo S, Cheng X, et al. Clinical features and long exercise test in Chinese patients with Andersen-Tawil syndrome. Muscle Nerve. 2016;54(6):1059-1063. doi:10.1002/mus.25169
Fontaine B. Muscle channelopathies and related diseases. Handb Clin Neurol. 2013;113:1433-1436. doi:10.1016/B978-0-444-59565-2.00012-5
Statland JM, Fontaine B, Hanna MG, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve. 2018;57(4):522. doi:10.1002/MUS.26009
Bendahhou S, Fournier E, Gallet S, Ménard D, Larroque MM, Barhanin J. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred. Hum Mol Genet. 2007;16(8):900-906. doi:10.1093/hmg/ddm034
Yoon G, Oberoi S, Tristani-Firouzi M, et al. Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype. Am J Med Genet. 2006;140A(4):312-321. doi:10.1002/ajmg.a.31092
Kostera-Pruszczyk A, Potulska-Chromik A, Pruszczyk P, et al. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement. Muscle Nerve. 2015;51(2):192-196. doi:10.1002/mus.24293
Tristani-Firouzi M, Jensen JL, Donaldson MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest. 2002;110(3):381-388. doi:10.1172/JCI15183
Lefter S, Hardiman O, Costigan D, et al. Andersen-Tawil syndrome with early fixed myopathy. J Clin Neuromuscul Dis. 2014;16(2):79-82. doi:10.1097/CND.0000000000000052
Jurkat-Rott K, Weber MA, Fauler M, et al. K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci USA. 2009;106(10):4036-4041. doi:10.1073/pnas.0811277106
Weber MA, Nielles-Vallespin S, Essig M, Jurkat-Rott K, Kauczor HU, Lehmann-Horn F. Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology. 2006;67(7):1151-1158. doi:10.1212/01.wnl.0000233841.75824.0f
Amarteifio E, Nagel AM, Weber MA, Jurkat-Rott K, Lehmann-Horn F. Hyperkalemic periodic paralysis and permanent weakness: 3-T MR imaging depicts intracellular 23Na overload-initial results. Radiology. 2012;264(1):154-163. doi:10.1148/radiol.12110980
Preisig-Müller R, Schlichthörl G, Goerge T, et al. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci USA. 2002;99(11):7774-7779. doi:10.1073/pnas.102609499
Seebohm G, Strutz-Seebohm N, Ursu ON, et al. Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome. FASEB J. 2012;26(2):513-522. doi:10.1096/fj.11-189126
Donaldson MR, Jensen JL, Tristani-Firouzi M, et al. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology. 2003;60(11):1811-1816. doi:10.1212/01.WNL.0000072261.14060.47
Eckhardt LL, Farley AL, Rodriguez E, et al. KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties. Hear Rhythm. 2007;4(3):323-329. doi:10.1016/J.HRTHM.2006.10.025
Karschin C, Dißmann E, Stühmer W, Karschin A. IRK(1-3) and GIRK(1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain. J Neurosci. 1996;16(11):3559-3570. doi:10.1523/jneurosci.16-11-03559.1996
Lam D, Schlichter LC. Expression and contributions of the Kir2.1 inward-rectifier K+ channel to proliferation, migration and chemotaxis of microglia in unstimulated and anti-inflammatory states. Front Cell Neurosci. 2015;9:185. doi:10.3389/fncel.2015.00185